Abortion rights are under threat in states across the country and at the Supreme Court, but women seeking the right to make their own medical decisions had an important win on Thursday. The Food and Drug Administration ended a requirement that mifepristone, frequently called the abortion pill, be dispensed in person, allowing the pills to be mailed going forward. The FDA had previously waived the in-person requirement due to the coronavirus pandemic, but on Thursday the elimination of the requirement was made permanent. Mifepristone, which is used in combination with another drug, misoprostol, remains a prescription drug, but now it can be prescribed at a telehealth appointment and obtained through the mail. Medication abortion can be used up to 10 weeks gestation. Read more